Tricia J. Vos

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

Mark Manfredi, Jeffrey Ecsedy, Kristan Meetze et al. · Proceedings of the National Academy of Sciences · 2007 · 413 citations · Full text

Tumor Biology, Active Small-molecule Inhibitor, Antitumor Activity +15

MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors

Todd B. Sells, Ryan Chau, Jeffrey Ecsedy et al. · ACS Medicinal Chemistry Letters · 2015 · 108 citations · Full text

Aurora A, Immunology, Molecular Biology +19

Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1<i>H</i>-imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model

Tricia J. Vos, Andrei Caracoti, L. McGlothan Jennifer et al. · Journal of Medicinal Chemistry · 2004 · 100 citations · Full text

Food Intake, Tumor Biology, Gastrointestinal Peptide Hormone +23

An Enyne Metathesis/(4 + 2)- Dimerization Route to (±)-Differolide

Thomas R. Hoye, Scott M. Donaldson, Tricia J. Vos · Organic Letters · 1999 · 84 citations

Enantioselective Synthesis, Derivatives, Engineering +13

Plk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines

Denise L. Driscoll, Arijit Chakravarty, Doug Bowman et al. · PLoS ONE · 2014 · 58 citations · Full text

Genome Instability, Cell Regulation, Cell Division +15